Auto-Immune Hepatitis in 2014, Bastia, 18-20 June 2014

被引:0
作者
Domont, F. [1 ,4 ,5 ]
Cacoub, P. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Paris 06, Dept Hosp Univ I2B, F-75005 Paris, France
[2] INSERM, UMR S 959, F-75013 Paris, France
[3] CNRS, UMR 7211, F-75005 Paris, France
[4] Grp Hosp Pitie Salpetriere, AP HP, Dept Med Interne, F-75651 Paris 13, France
[5] Grp Hosp Pitie Salpetriere, AP HP, Immunol Clin, F-75651 Paris 13, France
来源
REVUE DE MEDECINE INTERNE | 2014年 / 35卷
关键词
CONTROLLED-TRIAL; REMISSION; THERAPY; MANAGEMENT; AZATHIOPRINE; MAINTENANCE; INTOLERANT; PREDNISONE; RITUXIMAB; DIAGNOSIS;
D O I
10.1016/j.revmed.2014.03.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A6 / A10
页数:5
相关论文
共 41 条
  • [1] Rituximab for refractory autoimmune hepatitis: A case report
    Al-Busafi, Said A.
    Michel, Rene P.
    Deschenes, Marc
    [J]. ARAB JOURNAL OF GASTROENTEROLOGY, 2013, 14 (03) : 135 - 138
  • [2] Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis
    Al-Chalabi, Thawab
    Underhill, James A.
    Portmann, Bernard C.
    McFarlane, Ian G.
    Heneghan, Michael A.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (01) : 140 - 147
  • [3] Short-term cyclosporine induces a remission of autoimmune hepatitis in children
    Alvarez, F
    Ciocca, M
    Cañero-Velasco, C
    Ramonet, M
    de Davila, MTG
    Cuarterolo, M
    Gonzalez, T
    Jara-Vega, P
    Camarena, C
    Brochu, P
    Drut, R
    Alvarez, E
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (02) : 222 - 227
  • [4] Barth E, 2010, Case Rep Gastroenterol, V4, P502, DOI 10.1159/000322693
  • [5] Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy
    Burak, Kelly W.
    Swain, Mark G.
    Santodomino-Garzon, Tania
    Lee, Samuel S.
    Urbanski, Stefan J.
    Aspinall, Alexander I.
    Coffin, Carla S.
    Myers, Robert P.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 27 (05): : 273 - 280
  • [6] Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly
    Chen, J.
    Eslick, G. D.
    Weltman, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (02) : 117 - 124
  • [7] CONTROLLED PROSPECTIVE TRIAL OF CORTICOSTEROID THERAPY IN ACTIVE CHRONIC HEPATITIS
    COOK, GC
    MULLIGAN, R
    SHERLOCK, S
    [J]. QUARTERLY JOURNAL OF MEDICINE, 1971, 40 (158): : 159 - +
  • [8] Autoimmune hepatitis: Diagnostic and therapeutic up-to-date
    Corpechot, C.
    Chazouilleres, O.
    [J]. REVUE DE MEDECINE INTERNE, 2010, 31 (09): : 606 - 614
  • [9] Diagnosis and treatment of autoimmune hepatitis
    Czaja, AJ
    Freesel, DK
    [J]. HEPATOLOGY, 2002, 36 (02) : 479 - 497
  • [10] Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo-controlled treatment trial
    Czaja, AJ
    Carpenter, HA
    Lindor, KD
    [J]. HEPATOLOGY, 1999, 30 (06) : 1381 - 1386